Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  HIV Infection

  Free Subscription

Articles published in PLoS Med

Retrieve available abstracts of 52 articles:
HTML format

Single Articles

    November 2021
  1. NDLOVU Z, Ellman T
    Lay testing cadres and point-of-care diagnostic tests for HIV and other diseases: An essential combination in health service delivery.
    PLoS Med. 2021;18:e1003867.
    PubMed     Abstract available

  2. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    PubMed     Abstract available

  3. BULSTRA CA, Hontelez JAC, Otto M, Stepanova A, et al
    Integrating HIV services and other health services: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003836.
    PubMed     Abstract available

  4. HONTELEZ JAC, Bulstra CA, Yakusik A, Lamontagne E, et al
    Evidence-based policymaking when evidence is incomplete: The case of HIV programme integration.
    PLoS Med. 2021;18:e1003835.
    PubMed     Abstract available

    October 2021
  5. BIRDTHISTLE I, Kwaro D, Shahmanesh M, Baisley K, et al
    Evaluating the impact of DREAMS on HIV incidence among adolescent girls and young women: A population-based cohort study in Kenya and South Africa.
    PLoS Med. 2021;18:e1003837.
    PubMed     Abstract available

  6. AMSTUTZ A, Lejone TI, Khesa L, Kopo M, et al
    Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial.
    PLoS Med. 2021;18:e1003839.
    PubMed     Abstract available

  7. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    PubMed     Abstract available

  8. BARRY H, Mutua G, Kibuuka H, Anywaine Z, et al
    Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
    PLoS Med. 2021;18:e1003813.
    PubMed     Abstract available

  9. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    PubMed     Abstract available

    September 2021
  10. FORD N, Eshun-Wilson I, Ameyan W, Newman M, et al
    Future directions for HIV service delivery research: Research gaps identified through WHO guideline development process.
    PLoS Med. 2021;18:e1003812.
    PubMed     Abstract available

  11. HICKEY MD, Ayieko J, Owaraganise A, Sim N, et al
    Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003803.
    PubMed     Abstract available

  12. HERCE ME, Chagomerana MB, Zalla LC, Carbone NB, et al
    Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    PLoS Med. 2021;18:e1003780.
    PubMed     Abstract available

  13. MACPHERSON P, Webb EL, Kamchedzera W, Joekes E, et al
    Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003752.
    PubMed     Abstract available

  14. BASTOS ML, Melnychuk L, Campbell JR, Oxlade O, et al
    The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003703.
    PubMed     Abstract available

  15. AULD AF, Kerkhoff AD, Hanifa Y, Wood R, et al
    Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    PLoS Med. 2021;18:e1003739.
    PubMed     Abstract available

  16. UPPAL A, Rahman S, Campbell JR, Oxlade O, et al
    Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003712.
    PubMed     Abstract available

  17. YANES-LANE M, Ortiz-Brizuela E, Campbell JR, Benedetti A, et al
    Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    PLoS Med. 2021;18:e1003738.
    PubMed     Abstract available

  18. OXLADE O, Rochon H, Campbell JR, Menzies D, et al
    Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
    PLoS Med. 2021;18:e1003702.
    PubMed     Abstract available

  19. NAGATA JM, Epstein A, Ganson KT, Benmarhnia T, et al
    Drought and child vaccination coverage in 22 countries in sub-Saharan Africa: A retrospective analysis of national survey data from 2011 to 2019.
    PLoS Med. 2021;18:e1003678.
    PubMed     Abstract available

  20. ZULAIKA G, Nyothach E, van Eijk AM, Obor D, et al
    Factors associated with the prevalence of HIV, HSV-2, pregnancy, and reported sexual activity among adolescent girls in rural western Kenya: A cross-sectional analysis of baseline data in a cluster randomized controlled trial.
    PLoS Med. 2021;18:e1003756.
    PubMed     Abstract available

    June 2021
  21. HANUM N, Cambiano V, Sewell J, Rodger AJ, et al
    Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study.
    PLoS Med. 2021;18:e1003677.
    PubMed     Abstract available

  22. CELUM C, Hosek S, Tsholwana M, Kassim S, et al
    PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    PLoS Med. 2021;18:e1003670.
    PubMed     Abstract available

  23. DE LAY PR, Benzaken A, Karim QA, Aliyu S, et al
    Ending AIDS as a public health threat by 2030: Time to reset targets for 2025.
    PLoS Med. 2021;18:e1003649.
    PubMed     Abstract available

    May 2021
  24. ESHUN-WILSON I, Awotiwon AA, Germann A, Amankwaa SA, et al
    Effects of community-based antiretroviral therapy initiation models on HIV treatment outcomes: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003646.
    PubMed     Abstract available

  25. EHRENKRANZ P, Rosen S, Boulle A, Eaton JW, et al
    The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals.
    PLoS Med. 2021;18:e1003651.
    PubMed     Abstract available

  26. KINUTHIA J, Ronen K, Unger JA, Jiang W, et al
    SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial.
    PLoS Med. 2021;18:e1003650.
    PubMed     Abstract available

  27. SATINSKY EN, Kakuhikire B, Baguma C, Rasmussen JD, et al
    Adverse childhood experiences, adult depression, and suicidal ideation in rural Uganda: A cross-sectional, population-based study.
    PLoS Med. 2021;18:e1003642.
    PubMed     Abstract available

  28. CATTAMANCHI A, Crowder R, Kityamuwesi A, Kiwanuka N, et al
    Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
    PLoS Med. 2021;18:e1003628.
    PubMed     Abstract available

  29. CHAMIE G, Kwarisiima D, Ndyabakira A, Marson K, et al
    Financial incentives and deposit contracts to promote HIV retesting in Uganda: A randomized trial.
    PLoS Med. 2021;18:e1003630.
    PubMed     Abstract available

  30. KATCHER T, Thimmesch R, Spitz A, Kulkarni L, et al
    Sexual and reproductive health information and referrals for resettled refugee women: A survey of resettlement agencies in the United States.
    PLoS Med. 2021;18:e1003579.
    PubMed     Abstract available

  31. SHADE SB, Kirby VB, Stephens S, Moran L, et al
    Outcomes and costs of publicly funded patient navigation interventions to enhance HIV care continuum outcomes in the United States: A before-and-after study.
    PLoS Med. 2021;18:e1003418.
    PubMed     Abstract available

  32. INDRAVUDH PP, Fielding K, Kumwenda MK, Nzawa R, et al
    Effect of community-led delivery of HIV self-testing on HIV testing and antiretroviral therapy initiation in Malawi: A cluster-randomised trial.
    PLoS Med. 2021;18:e1003608.
    PubMed     Abstract available

    April 2021
  33. CALDERWOOD CJ, Wilson JP, Fielding KL, Harris RC, et al
    Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003566.
    PubMed     Abstract available

  34. SHADE SB, Marseille E, Kirby V, Chakravarty D, et al
    Health information technology interventions and engagement in HIV care and achievement of viral suppression in publicly funded settings in the US: A cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003389.
    PubMed     Abstract available

    March 2021
  35. JANSE VAN RENSBURG GH, Feucht UD, Makin J, le Clus N, et al
    Healthcare without borders: A cross-sectional study of immigrant and nonimmigrant children admitted to a large public sector hospital in the Gauteng Province of South Africa.
    PLoS Med. 2021;18:e1003565.
    PubMed     Abstract available

  36. KELLY HA, Chikandiwa A, Sawadogo B, Gilham C, et al
    Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    PLoS Med. 2021;18:e1003528.
    PubMed     Abstract available

  37. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    PubMed     Abstract available

  38. BOR J, Gage A, Onoya D, Maskew M, et al
    Variation in HIV care and treatment outcomes by facility in South Africa, 2011-2015: A cohort study.
    PLoS Med. 2021;18:e1003479.
    PubMed     Abstract available

    February 2021
  39. POLITCH JA, Cu-Uvin S, Moench TR, Tashima KT, et al
    Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
    PLoS Med. 2021;18:e1003495.
    PubMed     Abstract available

  40. KOSS CA, Havlir DV, Ayieko J, Kwarisiima D, et al
    HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003492.
    PubMed     Abstract available

    January 2021
  41. CHANG LW, Mbabali I, Hutton H, Amico KR, et al
    Novel community health worker strategy for HIV service engagement in a hyperendemic community in Rakai, Uganda: A pragmatic, cluster-randomized trial.
    PLoS Med. 2021;18:e1003475.
    PubMed     Abstract available

  42. MEFFERT SM, Neylan TC, McCulloch CE, Blum K, et al
    Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: Randomized controlled trial.
    PLoS Med. 2021;18:e1003468.
    PubMed     Abstract available

  43. STELZLE D, Godfrey-Faussett P, Jia C, Amiesimaka O, et al
    Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    PLoS Med. 2021;18:e1003482.
    PubMed     Abstract available

    December 2020
  44. RICKS S, Denkinger CM, Schumacher SG, Hallett TB, et al
    The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    PLoS Med. 2020;17:e1003466.
    PubMed     Abstract available

  45. HAUSER A, Kusejko K, Johnson LF, Gunthard HF, et al
    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    PLoS Med. 2020;17:e1003397.
    PubMed     Abstract available

    November 2020
  46. SCULIER D, Wandeler G, Yerly S, Marinosci A, et al
    Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
    PLoS Med. 2020;17:e1003421.
    PubMed     Abstract available

  47. BAIK Y, Rickman HM, Hanrahan CF, Mmolawa L, et al
    A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    PLoS Med. 2020;17:e1003420.
    PubMed     Abstract available

  48. PSIHOPAIDAS D, Cohen SM, West T, Avery L, et al
    Implementation science and the Health Resources and Services Administration's Ryan White HIV/AIDS Program's work towards ending the HIV epidemic in the United States.
    PLoS Med. 2020;17:e1003128.
    PubMed     Abstract available

  49. ASGARY R, Staderini N, Mthethwa-Hleta S, Lopez Saavedra PA, et al
    Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: A cohort study.
    PLoS Med. 2020;17:e1003378.
    PubMed     Abstract available

    October 2020
  50. ZHANG C, Koniak-Griffin D, Qian HZ, Goldsamt LA, et al
    Impact of providing free HIV self-testing kits on frequency of testing among men who have sex with men and their sexual partners in China: A randomized controlled trial.
    PLoS Med. 2020;17:e1003365.
    PubMed     Abstract available

  51. YAPA HM, De Neve JW, Chetty T, Herbst C, et al
    The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial.
    PLoS Med. 2020;17:e1003150.
    PubMed     Abstract available

  52. BERNARD CL, Rao IJ, Robison KK, Brandeau ML, et al
    Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.
    PLoS Med. 2020;17:e1003239.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.